Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study.

Sandro Pignata, Andrew R. Clamp, Geoff Hall et al.|Journal of Clinical Oncology|2022

Cited by 5